Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Dementia
Dementia is a condition that affects a person’s thinking, their behaviour and their ability to perform everyday tasks. There are more than 100 different causes of dementia, including Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Dementia is more common in older people, although people under 65 can develop so called younger onset dementia. Learn about common dementia worries, how to prepare your home environment and caring for someone with dementia in this section.
Dementia
Dementia is an umbrella term that refers to symptoms caused by changes in the functioning of the brain that affect memory, personality and behaviour. ...
Worried about dementia?
You might be worried you or a family member has dementia. Learn tips to help you understand the early signs of dementia and how to raise concerns with...
Dementia and your home
Making your home environment safe and comfortable for a person with dementia is very important. Find out more by reading these helpful resources.
Alzheimer's disease
Alzheimer's disease affects the brain functions, memory and behaviour. Find out about symptoms, how it’s diagnosed, and how to help delay its onset.
Younger onset dementia
People under 65 can develop so-called younger onset dementia. Learn about planning, legal rights and respite care for people with early onset dementia...
Caring for someone with dementia
Caring for someone with dementia can be frustrating and stressful at times, but there are organisations that can help with training and support.
Respite care for carers of people with dementia
There are many ways to get respite care. Here is some information about the different types of respite care available and programs to look into.
Dementia and driving
Dementia can affect your memory, concentration, judgement and vision, which can make driving a car more difficult. Learn about how it can affect drivi...
Need more information?
These trusted information partners have more on this topic.
Top results
Dementia (Alzheimer's disease) carers' information video | myVMC
Caring for people with dementia or Alzheimer's disease is challenging. This video presents practical strategies for caring for Alzheimer's carers.
Read more on myVMC – Virtual Medical Centre website
Dementia (Alzheimer's disease) information video | myVMC
Living with dementia and providing dementia care can be difficult. Watch tips and advice from doctors and people with Alzheimers disease in this video.
Read more on myVMC – Virtual Medical Centre website
Preventing dementia (Alzheimer's disease) video information | myVMC
Dementia or Alzheimer's disease may be prevented with blood pressure lowering therapies (antihypertension treatment) and other heart health measures.
Read more on myVMC – Virtual Medical Centre website
Dementia Australia | Alzheimer's disease
Alzheimers disease is the most common form of dementia, affecting up to 70% of all people with dementia Quick facts Alzheimer's disease damages the brain, resulting in impaired memory, thinking and behaviour The biggest risk factor for having Alzheimers disease is increasing age, with three in ten people over 85 having dementia Sporadic Alzheimers disease can affect anyone of any age Familial Alzheimers disease is a very rare genetic condition, with an age of onset of less than 65 years
Read more on Dementia Australia website
Brain Foundation | Dementia (Non-Alzheimer type)
Dementia (Non-Alzheimer type) Dementia (Non-Alzheimer type) (See also Alzheimers Disease) Description The term dementia is used to describe the pattern of deteriorating intellectual function particularly (although not exclusively) in the elderly that can occur as a result of various neurological disorders
Read more on Brain Foundation website
Alzheimers disease
Alzheimers disease is a form of dementia.
Read more on WA Health website
Dementia Australia | Alzheimer's disease
Alzheimers disease is the most common form of dementia, affecting up to 70% of all people with dementia Quick facts Alzheimer's disease damages the brain, resulting in impaired memory, thinking and behaviour The biggest risk factor for having Alzheimers disease is increasing age, with three in ten people over 85 having dementia Sporadic Alzheimers disease can affect anyone of any age Familial Alzheimers disease is a very rare genetic condition, with an age of onset of less than 65 years
Read more on Dementia Australia website
Brain Foundation | Alzheimers Disease
Alzheimers Disease Alzheimers Disease Description Alzheimer's Disease is a form of dementia a neurodegenerative disease that damages the brain's intellectual functions (memory, orientation, calculation, etc
Read more on Brain Foundation website
Dementia Australia | Dementia research
Researchers are currently investigating a number of aspects of dementia. Research into the causes of dementia There is still much to learn about the possible causes of dementia, including Alzheimer's disease - the most common form of dementia.
Read more on Dementia Australia website
Dementia Australia | Vascular dementia
Vascular dementia is the second most common cause of dementia after Alzheimer's disease. What is vascular dementia? Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. Are there different types of vascular dementia? There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease.
Read more on Dementia Australia website
Top results
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia | Cochrane
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
Read more on Cochrane (Australasian Centre) website
Donepezil is beneficial for people with mild, moderate and severe dementia due to Alzheimer's disease | Cochrane
Donepezil is beneficial for people with mild, moderate and severe dementia due to Alzheimer's disease
Read more on Cochrane (Australasian Centre) website
Proteins in blood and cerebrospinal fluids for early prediction of developing Alzheimers disease or other dementia in people with cognitive problems | Cochrane
Proteins in blood and cerebrospinal fluids for early prediction of developing Alzheimers disease or other dementia in people with cognitive problems
Read more on Cochrane (Australasian Centre) website
11C-PIB-PET scan for early prediction of developing Alzheimers disease or other dementia in people with mild cognitive impairment (MCI) | Cochrane
11C-PIB-PET scan for early prediction of developing Alzheimers disease or other dementia in people with mild cognitive impairment (MCI)
Read more on Cochrane (Australasian Centre) website
F-FDG PET scan for early prediction of developing Alzheimers disease or other dementia in people with mild cognitive impairment (MCI) | Cochrane
F-FDG PET scan for early prediction of developing Alzheimers disease or other dementia in people with mild cognitive impairment (MCI)
Read more on Cochrane (Australasian Centre) website
Montreal Cognitive Assessment (MoCA) for the diagnosis of Alzheimer's disease and other dementias | Cochrane
We reviewed the evidence about the accuracy of the Montreal Cognitive Assessment (MoCA) test for diagnosing dementia and its subtypes.
Read more on Cochrane (Australasian Centre) website
Statins for the prevention of dementia | Cochrane
Dementia (including Alzheimer's disease) is a global healthcare concern; the number of people affected worldwide is predicted to double every 20 years, reaching 74.7 million in 2010 and 131.5 million in 2050. Therefore, it is important to find means of preventing dementia. It has been suggested that high levels of cholesterol in the serum (part of the blood) may increase the risk of dementia and that treatment with cholesterol-lowering medicines such as statins may reduce the risk of dementia.
Read more on Cochrane (Australasian Centre) website
Velnacrine is not beneficial for people with Alzheimer's disease | Cochrane
Alzheimer's disease (AD) is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in relevant parts of the brain by the use of cholinesterase inhibitors to delay the breakdown of acetylcholine released into synaptic clefts. Tacrine, the first of the cholinesterase inhibitors to undergo extensive trials for this purpose, was associated with significant adverse effects including hepatotoxicity. Velnacrine is a derivative of tacrine. There is evidence that it is toxic in a similar way to tacrine and all research stopped in 1994. The FDA peripheral and CNS drug advisory board voted unanimously against recommending approval.
Read more on Cochrane (Australasian Centre) website
Doubtful effect of lecithin as a treatment for dementia | Cochrane
Lecithin is a major dietary source of choline, a substance that may theoretically improve brain functioning in people with dementia or similar problems (including Alzheimer's disease). This review did not find any evidence that lecithin does have a benefit for patients with Alzheimer's disease or other forms of dementia. However, one small study has observed a dramatic benefit of lecithin in people with subjective memory problems, but there are no similar studies with which to compare it.
Read more on Cochrane (Australasian Centre) website
No evidence of efficacy of alpha lipoic acid for dementia | Cochrane
Alpha lipoic acid (ALA) is one of a number of potent antioxidants for which a potential therapeutic role in dementia has been postulated. This suggestion arises from the possibility that oxidative and inflammatory processes contribute to the neurodegeneration of Alzheimer's disease. Whilst ALA has been used as part of the treatment for a variety of neurological disorders, no placebo-controlled randomized trials have been conducted for its use in degenerative dementias. ALA for the treatment of dementia of any subtype cannot currently be recommended.
Read more on Cochrane (Australasian Centre) website
